Change Healthcare Inc.

2022 Q3 Form 10-Q Financial Statement

#000175649722000011 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.01M $252.3M
YoY Change -13.84% 123.07%
Cash & Equivalents $94.01M $252.3M
Short-Term Investments
Other Short-Term Assets $204.4M $74.64M
YoY Change 38.23% 38.34%
Inventory
Prepaid Expenses $103.0M
Receivables $717.7M $720.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.146B $1.313B
YoY Change 0.96% 17.35%
LONG-TERM ASSETS
Property, Plant & Equipment $126.8M $141.3M
YoY Change -22.12% -18.94%
Goodwill $4.102B $4.113B
YoY Change -0.26% 0.1%
Intangibles $3.587B $3.700B
YoY Change -11.75% -11.64%
Long-Term Investments
YoY Change
Other Assets $613.7M $600.1M
YoY Change 30.41% 39.5%
Total Long-Term Assets $8.491B $8.620B
YoY Change -4.56% -4.16%
TOTAL ASSETS
Total Short-Term Assets $1.146B $1.313B
Total Long-Term Assets $8.491B $8.620B
Total Assets $9.637B $9.932B
YoY Change -3.94% -1.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $85.21M $104.3M
YoY Change -8.03% 81.51%
Accrued Expenses $383.4M $461.5M
YoY Change -15.44% -4.71%
Deferred Revenue $410.0M $469.1M
YoY Change 1.59% 7.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.708M $10.01M
YoY Change -79.62% -63.4%
Total Short-Term Liabilities $932.8M $1.080B
YoY Change -7.96% 3.11%
LONG-TERM LIABILITIES
Long-Term Debt $4.487B $4.580B
YoY Change -5.25% -3.27%
Other Long-Term Liabilities $68.58M $73.12M
YoY Change 6.17% 11.51%
Total Long-Term Liabilities $4.555B $4.653B
YoY Change -5.1% -3.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $932.8M $1.080B
Total Long-Term Liabilities $4.555B $4.653B
Total Liabilities $6.346B $6.656B
YoY Change -6.23% -2.97%
SHAREHOLDERS EQUITY
Retained Earnings -$1.123B -$1.100B
YoY Change 7.35% 5.5%
Common Stock $327.0K $313.0K
YoY Change 5.14% 1.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.291B $3.276B
YoY Change
Total Liabilities & Shareholders Equity $9.637B $9.932B
YoY Change -3.94% -1.78%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001756497
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-38961
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
Change Healthcare Inc.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2152098
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
424 Church Street
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1400
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37219
CY2022Q2 dei City Area Code
CityAreaCode
615
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
932-3000
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
CHNG
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
328308520
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
884469000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
867856000
CY2022Q2 us-gaap Postage Expense
PostageExpense
53126000
CY2021Q2 us-gaap Postage Expense
PostageExpense
51208000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74197000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71240000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
197886000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
177955000
CY2022Q2 chng Cost Of Operations Excluding Depreciation Depletion And Amortization
CostOfOperationsExcludingDepreciationDepletionAndAmortization
357096000
CY2021Q2 chng Cost Of Operations Excluding Depreciation Depletion And Amortization
CostOfOperationsExcludingDepreciationDepletionAndAmortization
352063000
CY2022Q2 us-gaap Interest Expense
InterestExpense
56870000
CY2021Q2 us-gaap Interest Expense
InterestExpense
59386000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
720122000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-390000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2472000
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
130351000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
171722000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
168211000
CY2022Q2 chng Accretion Expense Related Party
AccretionExpenseRelatedParty
3189000
CY2021Q2 chng Accretion Expense Related Party
AccretionExpenseRelatedParty
3037000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
857216000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
823714000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27253000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
44142000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3189000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59732000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56197000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32479000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12055000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9311000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8450000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23168000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3605000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
326562482
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
326562482
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322546171
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
322546171
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23168000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3605000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-12098000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3571000
CY2022Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
-6159000
CY2021Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
-119000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5939000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3690000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-29107000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
85000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94009000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
252298000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
717684000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1312907000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126781000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141340000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61423000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
162828000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65680000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204357000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
177659000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1146401000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
313000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Goodwill
Goodwill
4101659000
CY2022Q1 us-gaap Goodwill
Goodwill
4112904000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3587019000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3699603000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
613698000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
600061000
CY2022Q2 us-gaap Assets
Assets
9636981000
CY2022Q1 us-gaap Assets
Assets
9932495000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
85208000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
104273000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
383368000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
461506000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
409952000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
469098000
CY2022Q2 chng Due To Related Parties Net Current
DueToRelatedPartiesNetCurrent
29560000
CY2022Q1 chng Due To Related Parties Net Current
DueToRelatedPartiesNetCurrent
13057000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4708000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
10006000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20009000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21726000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
932805000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1079666000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4486565000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4580087000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48580000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52286000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
555616000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
563606000
CY2022Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
79503000
CY2022Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
104863000
CY2022Q2 chng Tax Receivable Agreement Obligation
TaxReceivableAgreementObligation
174445000
CY2022Q1 chng Tax Receivable Agreement Obligation
TaxReceivableAgreementObligation
202762000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
68581000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
73118000
CY2022Q2 us-gaap Liabilities
Liabilities
6346095000
CY2022Q1 us-gaap Liabilities
Liabilities
6656388000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9000000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9000000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
326971095
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
326971095
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
313131714
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
313131714
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
327000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
900000000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3290886000
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
26166000
CY2022Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-10411000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-8989000
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4384631000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4340759000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29177000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35116000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1123249000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1100081000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
900000000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3276107000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9636981000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9932495000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3252228000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23191000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1445000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-13016000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3605000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3571000
CY2021Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
-119000
CY2021Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-80000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3263853000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3276107000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49064000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1365000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-6407000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23168000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-12098000
CY2022Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
-6159000
CY2022Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-136000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3290886000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23168000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3605000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
171722000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
168211000
CY2022Q2 chng Capitalized Software Developed For Sale Amortization Expense
CapitalizedSoftwareDevelopedForSaleAmortizationExpense
1302000
CY2021Q2 chng Capitalized Software Developed For Sale Amortization Expense
CapitalizedSoftwareDevelopedForSaleAmortizationExpense
717000
CY2022Q2 chng Accretion And Changes In Estimate Net
AccretionAndChangesInEstimateNet
4800000
CY2021Q2 chng Accretion And Changes In Estimate Net
AccretionAndChangesInEstimateNet
4732000
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
49961000
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7770000
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7910000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1991000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11773000
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
470000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-158289000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3997000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-30028000
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
3090000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252298000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-390000
CY2022Q2 chng Noncash Lease Expense
NoncashLeaseExpense
5681000
CY2021Q2 chng Noncash Lease Expense
NoncashLeaseExpense
7007000
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3916000
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-249000
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20811000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25029000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2481000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34722000
CY2022Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-75394000
CY2021Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-53649000
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-61981000
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-33472000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83315000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110107000
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
79535000
CY2021Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
66006000
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79535000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67006000
CY2022Q2 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
100000000
CY2022Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
48462000
CY2021Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
21537000
CY2022Q2 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
410000
CY2021Q2 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
7364000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6407000
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13015000
CY2022Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2331000
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6796000
CY2022Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
4254000
CY2021Q2 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3965000
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1274000
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5225000
CY2022Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-58000
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-116000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-160648000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47568000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1421000
CY2022Q2 chng Tax Receivable Agreement Obligation Noncurrent
TaxReceivableAgreementObligationNoncurrent
253948000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113101000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94009000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109104000
CY2022Q2 chng Derivative Instruments Reclassified From Accumulated Oci Into Interest Expense
DerivativeInstrumentsReclassifiedFromAccumulatedOciIntoInterestExpense
18424000
CY2022Q2 chng Termination Fee If Alternative Transaction Subsequently Consummated
TerminationFeeIfAlternativeTransactionSubsequentlyConsummated
300000000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
16996000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22224000
CY2022Q2 chng Tax Receivable Agreement Obligation Payments Due Next Twelve Months
TaxReceivableAgreementObligationPaymentsDueNextTwelveMonths
59772000
CY2022Q2 chng Tax Receivable Agreement Obligation Payments Due Year Two
TaxReceivableAgreementObligationPaymentsDueYearTwo
81695000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
10006000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22224000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
24126000
CY2022Q2 chng Accounts Receivable Allowance For Credit Loss Provisions
AccountsReceivableAllowanceForCreditLossProvisions
190000
CY2021Q2 chng Accounts Receivable Allowance For Credit Loss Provisions
AccountsReceivableAllowanceForCreditLossProvisions
1477000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5418000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2523000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
16996000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
23080000
CY2022Q2 chng Percentage Of Deferred Revenue Balances Expected To Be Recognized In One Year Or Less
PercentageOfDeferredRevenueBalancesExpectedToBeRecognizedInOneYearOrLess
0.93
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
139431000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
159230000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1392784000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.52
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.48
CY2022Q1 us-gaap Goodwill
Goodwill
4112904000
CY2022Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-11245000
CY2022Q2 us-gaap Goodwill
Goodwill
4101659000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4708000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4486565000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4580087000
CY2022Q2 chng Tax Receivable Agreement Obligation Payments Due Year Three
TaxReceivableAgreementObligationPaymentsDueYearThree
84691000
CY2022Q2 chng Tax Receivable Agreement Obligation Payments Due Year Four
TaxReceivableAgreementObligationPaymentsDueYearFour
49929000
CY2022Q2 chng Tax Receivable Agreement Obligation Payments Due Year After Year Five
TaxReceivableAgreementObligationPaymentsDueYearAfterYearFive
112821000
CY2022Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
34128000
CY2022Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
34128000
CY2022Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
25471000
CY2022Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
25471000
CY2022Q2 chng Debt Instrument Convertible Settlement
DebtInstrumentConvertibleSettlement
3.2051
CY2022Q2 chng Tax Receivable Agreement Obligation Gross
TaxReceivableAgreementObligationGross
388908000
CY2022Q2 chng Tax Receivable Agreement Obligation Discount
TaxReceivableAgreementObligationDiscount
75188000
CY2022Q2 chng Tax Receivable Agreement Obligation Current And Noncurrent
TaxReceivableAgreementObligationCurrentAndNoncurrent
313720000
CY2022Q2 chng Tax Receivable Agreement Obligation Current
TaxReceivableAgreementObligationCurrent
59772000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9311000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8450000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.287
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.701
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23168000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3605000
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
318127831
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
308882895
CY2022Q2 chng Weighted Average Number Of Shares Shares Issuable Under Purchase Contracts
WeightedAverageNumberOfSharesSharesIssuableUnderPurchaseContracts
8434651
CY2021Q2 chng Weighted Average Number Of Shares Shares Issuable Under Purchase Contracts
WeightedAverageNumberOfSharesSharesIssuableUnderPurchaseContracts
13663276
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
326562482
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
322546171
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q2 chng Acquisition And Divestiture Related Costs
AcquisitionAndDivestitureRelatedCosts
6394000
CY2022Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
9
CY2022Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
979000
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1770000
CY2022Q2 us-gaap Related Party Costs
RelatedPartyCosts
4079000
CY2021Q2 us-gaap Related Party Costs
RelatedPartyCosts
4253000
CY2022Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
884469000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
867856000
CY2022Q2 chng Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
280180000
CY2021Q2 chng Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
282728000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32479000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12055000
CY2022Q2 chng Capitalized Software Developed For Sale Amortization Expense
CapitalizedSoftwareDevelopedForSaleAmortizationExpense
1302000
CY2021Q2 chng Capitalized Software Developed For Sale Amortization Expense
CapitalizedSoftwareDevelopedForSaleAmortizationExpense
717000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
171722000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
168211000
CY2022Q2 us-gaap Interest Expense
InterestExpense
56870000
CY2021Q2 us-gaap Interest Expense
InterestExpense
59386000
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
49961000
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
26166000
CY2022Q2 chng Business Acquisition Accounting Adjustment
BusinessAcquisitionAccountingAdjustment
-4613000
CY2021Q2 chng Business Acquisition Accounting Adjustment
BusinessAcquisitionAccountingAdjustment
-559000
CY2022Q2 chng Acquisition And Divestiture Related Costs
AcquisitionAndDivestitureRelatedCosts
17944000
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1428000
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
11368000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-390000
CY2022Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
3583000
CY2022Q2 chng Strategic Initiatives Duplicative And Transition Costs
StrategicInitiativesDuplicativeAndTransitionCosts
5629000
CY2021Q2 chng Strategic Initiatives Duplicative And Transition Costs
StrategicInitiativesDuplicativeAndTransitionCosts
9928000
CY2022Q2 us-gaap Severance Costs1
SeveranceCosts1
2482000
CY2021Q2 us-gaap Severance Costs1
SeveranceCosts1
4720000
CY2022Q2 chng Accretion And Changes In Estimate Net
AccretionAndChangesInEstimateNet
4800000
CY2021Q2 chng Accretion And Changes In Estimate Net
AccretionAndChangesInEstimateNet
4732000
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1161000
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1612000
CY2021Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
2108000
CY2022Q2 chng Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
280180000
CY2021Q2 chng Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
282728000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49961000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26166000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
261373000

Files In Submission

Name View Source Status
0001756497-22-000011-index-headers.html Edgar Link pending
0001756497-22-000011-index.html Edgar Link pending
0001756497-22-000011.txt Edgar Link pending
0001756497-22-000011-xbrl.zip Edgar Link pending
chng-20220630.xsd Edgar Link pending
chng-20220630x10q.htm Edgar Link pending
chng-20220630x10qg001.jpg Edgar Link pending
chng-20220630x10q_htm.xml Edgar Link completed
chng-20220630xex10_1.htm Edgar Link pending
chng-20220630xex10_2.htm Edgar Link pending
chng-20220630xex10_3.htm Edgar Link pending
chng-20220630xex10_4.htm Edgar Link pending
chng-20220630xex10_5.htm Edgar Link pending
chng-20220630xex10_6.htm Edgar Link pending
chng-20220630xex31_1.htm Edgar Link pending
chng-20220630xex31_2.htm Edgar Link pending
chng-20220630xex32_1.htm Edgar Link pending
chng-20220630xex32_2.htm Edgar Link pending
chng-20220630_cal.xml Edgar Link unprocessable
chng-20220630_def.xml Edgar Link unprocessable
chng-20220630_lab.xml Edgar Link unprocessable
chng-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending